79279 Vorstetten, Germany

Thomas Boehm

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Boehm. Retrieved from https://idiyas.com/inventor/thomas-boehm-ahjg5gp8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal1 out of 834,570 
Other
 patents

Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Boehm: Innovator in Clonogenic Fibroblast Technology

Introduction

Thomas Boehm is a notable inventor based in Vorstetten, Germany. He has made significant contributions to the field of biotechnology, particularly in the preparation and use of clonogenic fibroblasts. His innovative work has led to the development of methods that are crucial for various applications in medical research and therapy.

Latest Patents

Thomas Boehm holds 1 patent for his invention titled "Methods for preparing and using clonogenic fibroblasts and transfected." This patent showcases his expertise in cellular biology and the potential for advancing therapeutic techniques.

Career Highlights

Throughout his career, Thomas has focused on pioneering research that bridges the gap between basic science and practical applications. His work has been instrumental in enhancing our understanding of fibroblast biology and its implications in regenerative medicine.

Collaborations

Thomas has collaborated with esteemed colleagues, including Albrecht Lindemann and Peter Kulmburg. These partnerships have fostered a rich environment for innovation and have contributed to the success of his research endeavors.

Conclusion

In summary, Thomas Boehm is a distinguished inventor whose work in clonogenic fibroblast technology has made a lasting impact in the field of biotechnology. His contributions continue to inspire advancements in medical research and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…